Liposome-encapsulated panomycocin: preparation, characterization and in vitro determination of antifungal efficacy against dermatophytes

Tosun, Kübra
Dermatopytosis is one of the most seen superficial fungal infections in humans resulting mild to severe inflammations. Antifungal drugs are not effective in the treatment of dermatophytosis due to serious adverse effects and resistance developed by fungal pathogens. Thus, the development of safe, naturally derived and potent antifungal/antimycotic agents which do not result in resistance and elicit little or no side effects to mammalian cells with high selectivity to the fungal pathogens is a continuing need. In this study, liposomal formulation of Panomycocin which is a novel and naturally derived killer protein produced by Pichia anomala was developed for treatment of human dermatophytosis. This study involves the preparation of Panomycocin loaded liposomes and their characterizations including in vitro biological activity test on tissue models against human dermatophytes. Panomycocin was encapsulated by stratum corneum lipid liposomes having lipid composition identical to that of the stratum corneum of mammalian cells where dermatophytes adhere to. The encapsulation and loading efficiencies of Panomycocin incorporated liposomes were calculated as 73 % and 76.8 %, respectively. TEM images revealed that liposome nanoparticles were in nano size with roughly spherical shape. Zeta potential and XRD analyses showed that liposomes were stable in collodial system and amorphous, respectively. Presence of covalent interactions between Panomycocin and liposomes were not observed by FTIR. DLS proved that liposomes were monodisperse in suspension without any aggregation. In vitro release tests determined that 1.71 % of Panomycocin was released from liposomes within 12 hours. The biological activity test on Reconstructed Human Epidermis tissue models against human dermatophytes indicated that developed formulation had an inhibitory effect on tested dermatophytes at similar MFC values which was previously published for pure Panomycocin. Liposomal formulation of Panomycocin prepared with stratum corneum lipids led up to further preclinical and clinical studies for the treatment of dermatophytosis.  


Liposome-encapsulated panomycocin: preparation, characterization and in-vitro determination of antifungal efficacy against vulvovaginal candidiasis
Bayram, Günce; İzgü, Kadri Fatih; Özkan, Yalçın; Department of Biotechnology (2016)
Vulvovaginal candidiasis is a serious yeast infection that affects 80% of all women worldwide. In this study, a liposomal lyophilized powder formulation of Panomycocin was developed for therapeutic purposes against vulvovaginal candidiasis. Panomycocin is a potent antimycotic/antifungal protein secreted by Pichia anomala NCYC 434 strain previously shown to be fungicidal against Candida species which are the causal agents of vulvovaginal candidiasis. This study consists of the preparation of stratum corneum ...
Panomycocin-incorporated chitosan-tpp nanoparticles : preparation, characterization and in vitro determination of antifungal activity against human dermatophytes
Elçin, Evrim; İzgü, Kadri Fatih; Department of Biotechnology (2013)
There is an increase in the incidence of superficial fungal infections. Especially, immuno-compromised patients, diabetic patients, obese and people having resistancy against a group of antifungal drugs are at great risk. In these patient groups the infection can become chronic and affect the deeper and living layers of the skin and can be life threatening if not treated effectively. However, drugs which are currently used in the therapy of dermatophyte infections are becoming less effective due to the seri...
VanA-Type MRSA (VRSA) Emerged in Surface Waters
İçgen, Bülent (Springer Science and Business Media LLC, 2016-09-01)
Due to the widespread occurrence of mecA-encoded methicillin resistance in Staphylococcus aureus (MRSA), treatment of staphylococcal infections is shifted to glycopeptide antibiotics like vancomycin and teicoplanin. The selective pressure of glycopeptides has eventually led to the emergence of staphylococci with increased resistance. Of great concern is vanA-encoded high level vancomycin and teicoplanin resistance in MRSA (VRSA). Therefore, this study aimed at investigating the occurrence of VRSA in surface...
Genomic characterization of pseudomonas aeruginosa clinical isolates by pulsed field gel electrophoresis method
Alipour Ghorbani, Nader; Yıldız, Fatih; Durmaz, Rıza; Department of Biotechnology (2014)
Pseudomonas aeruginosa is a common cause of nosocomial infections, particularly in intensive care units (ICUs), bronchoscopy, oncology, and urology. The aim of this study was to characterize P. aeruginosa clinical isolates clonally relatedness by pulsed-field gel electrophoresis (PFGE) typing and it’s cut off value determination. We did retrospective study and analyzed genotypically a collection of 58 clinical isolates recovered during the period 2006–2011 from MESA private hospital microbiology department’...
Liposomes as immunological adjuvants and vaccine carriers
Gregoriadis, G; Gursel, I; Gürsel, Mayda; McCormack, B (1996-08-01)
Work by numerous laboratories in the last two decades has shown that liposomes promote humoral and cell-mediated immunity to a large variety of bacterial, protozoan, viral and tumour cell antigens. This immunoadjuvant action of liposomes depends on their structural characteristics which control vesicle fate in vivo including the mode of antigen interaction with antigen-presenting cells. Liposomal adjuvanticity is further promoted by receptor mediated targeting to macrophages or the presence of co-adjuvants ...
Citation Formats
K. Tosun, “Liposome-encapsulated panomycocin: preparation, characterization and in vitro determination of antifungal efficacy against dermatophytes,” M.S. - Master of Science, Middle East Technical University, 2016.